These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4017468)

  • 1. [The significance of sulodexide in the prevention of obliterative atherosclerotic arterial disease of the lower limbs].
    Martino R; Benini D
    Clin Ter; 1985 Mar; 112(5):429-37. PubMed ID: 4017468
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experience with sulodexide (Vessel Due F) in diabetics with ischemic disease of the lower extremities].
    Utratová J; Mayer J; Elbl L; Vorlícek J; Prásek J
    Vnitr Lek; 1993 Jun; 39(6):575-80. PubMed ID: 8212613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of short-term sulodexide treatment on peripheral vascular disease clinical manifestations.
    Caramelli L; Mirchioni R; Carini A
    Riv Eur Sci Med Farmacol; 1988 Feb; 10(1):55-8. PubMed ID: 3079198
    [No Abstract]   [Full Text] [Related]  

  • 4. [Sulodexide treatment approach in patients with atherosclerotic vascular disease with various localizations].
    Capone-Braga M; Tellini L; Boncompagni L; Bettoni M; Burali A; Bensi A
    Clin Ter; 1987 Jan; 120(1):25-31. PubMed ID: 2973852
    [No Abstract]   [Full Text] [Related]  

  • 5. [Sulodexide in the therapy of vasculopathies].
    Postiglione F; Pisani P; Gisonni P; Perrotta P; Gisonni A; Canciello M; Napolitano L; Brighina G; Ragno I; Salzano A
    Clin Ter; 1986 May; 117(3):223-31. PubMed ID: 3524974
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment with mesoglycan of chronic obliterative atherosclerotic arteriopathies of the legs. Hematochemical and flowmetric changes].
    di Giovanna VN
    Clin Ter; 1988 Jun; 125(6):431-4. PubMed ID: 2973949
    [No Abstract]   [Full Text] [Related]  

  • 7. Preliminary results of sulodexide treatment in patients with peripheral arteriosclerosis and hyperlipidemia. A multicentre trial.
    Crepaldi G; Fellin R; Calabrò A; Baiocchi MR; Rossi A; Lenzi S; Descovich GC; Delmonte G; Gaddi A; Ventura A
    Monogr Atheroscler; 1986; 14():215-21. PubMed ID: 3526129
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of nifedipine on peripheral blood flow in patients with atherosclerotic arterial disease of the lower limbs. A controlled study].
    Savi L; Cardillo C; Guerrera G; Melina D
    Clin Ter; 1985 Mar; 112(5):419-22. PubMed ID: 4017466
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of ciclonicate in the treatment of obliterative arteriopathies of the lower limbs].
    Licata G; Pinto A; Parrinello G; Salli L; Indovina I
    Clin Ter; 1985 Mar; 112(6):503-13. PubMed ID: 4017475
    [No Abstract]   [Full Text] [Related]  

  • 10. [Polydistrectual atherosclerosis in the elderly. Ischemic cardiopathy and obliterative peripheral arteriopathy of the lower limbs].
    Cimino R; Bonacci E; Iannazzo P; D'Amico N; Mattace R
    Minerva Cardioangiol; 1997 May; 45(5):223-7. PubMed ID: 9273473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemorheology and tissue oxygenation in hypertensives with lipoidoproteinosis and peripheral occlusive arterial disease (POAD) treated with sulodexide and pravastatine and evaluated with laser assisted optical rotational red cell analyzer (LORCA) and transcutaneous oxymetry.
    Cicco G; Stingi GD; Vicenti P; Tarallo MS; Pirrelli A
    Minerva Cardioangiol; 1999 Oct; 47(10):351-9. PubMed ID: 10670256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulodexide: a renewed interest in this glycosaminoglycan.
    Lauver DA; Lucchesi BR
    Cardiovasc Drug Rev; 2006; 24(3-4):214-26. PubMed ID: 17214598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Action of cinnarizine on the blood flow of the lower limbs in patients affected by obliterative peripheral arterial disease and in normal subjects.
    Forconi S; Guerrini M; Di Perri T
    Vasa; 1976; 5(4):360-5. PubMed ID: 1007545
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pros and cons of vasodilator therapy in obliterative vascular diseases of the lower limbs].
    Thulesius O
    Lakartidningen; 1966 Oct; 63(43):4089-96. PubMed ID: 5977628
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies with Seniosan in arteriosclerosis of the abdominal aorta and-or lower extremities].
    Blomquist HE
    Ann Chir Gynaecol Fenn; 1968; 57(2):218-20. PubMed ID: 4237173
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effectiveness and tolerability of heparan sulfate in the treatment of superficial thrombophlebitis. Controlled clinical study vs sulodexide].
    Messa G; La Placa G; Puccetti L; Di Perri T
    Minerva Cardioangiol; 1997 Apr; 45(4):147-53. PubMed ID: 9213829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Statins in the treatment of patients with arterial occlusive disease of the lower extremities].
    Mayer O; Hromádka M
    Vnitr Lek; 2001 Oct; 47(10):664-9. PubMed ID: 11789002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Blood flow in obliterative atherosclerotic arteriopathies of the leg].
    Pratesi F
    Vestn Akad Med Nauk SSSR; 1980; (1):52-4. PubMed ID: 7368855
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of lumbar sympathectomy on arterial blood flow to the lower limbs].
    Rostad H; Dedichen H
    Nord Med; 1970 Apr; 83(15):465-7. PubMed ID: 5426413
    [No Abstract]   [Full Text] [Related]  

  • 20. A plethysmographic study of the spontaneous course of obliterative arterial disease in the lower leg.
    Ulrich J; Engell HC; Siggaard-Andersen J
    Scand J Clin Lab Invest Suppl; 1973; 128():75-81. PubMed ID: 4764603
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.